| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 2 | 12 | |
| BREAST | 974 | 23 | 1200 | 106 | 1291 | 196 | 1193 |
| ERLYTX | 97 | 1 | 52 | 6 | 73 | 13 | 79 |
| GI | 193 | 3 | 157 | 13 | 158 | 33 | 201 |
| GU | 446 | 5 | 261 | 37 | 450 | 65 | 396 |
| LEUK | 139 | 2 | 104 | 12 | 146 | 27 | 164 |
| LUNG | 243 | 4 | 209 | 17 | 207 | 25 | 152 |
| LYMPH | 385 | 10 | 522 | 30 | 365 | 62 | 377 |
| MELAN | 319 | 1 | 52 | 1 | 12 | 1 | 6 |
| MMYEL | 184 | 2 | 104 | 10 | 122 | 19 | 116 |
| MULT | 15 | 0 | 0 | 7 | 85 | 12 | 73 |
| OTHER | 38 | 2 | 104 | 3 | 37 | 6 | 37 |
| PREV | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| SXQOL | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3040 | 53 | 2765 | 242 | 2946 | 461 | 2806 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 1 | 6 | |
| CCD | 137 | 5 | 261 | 18 | 219 | 25 | 152 |
| ERLYTX | 11 | 0 | 0 | 1 | 12 | 1 | 6 |
| LEUK | 685 | 11 | 574 | 55 | 670 | 103 | 627 |
| LUNG | 287 | 5 | 261 | 29 | 353 | 69 | 420 |
| LYMPH | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| OTHER | 36 | 1 | 52 | 7 | 85 | 10 | 61 |
| PEOLC | 112 | 3 | 157 | 16 | 195 | 34 | 207 |
| PREV | 245 | 3 | 157 | 21 | 256 | 35 | 213 |
| SURV | 16 | 1 | 52 | 2 | 24 | 6 | 37 |
| SXQOL | 591 | 7 | 365 | 55 | 670 | 92 | 560 |
| Total | 2122 | 36 | 1879 | 204 | 2484 | 376 | 2289 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 3 | 0 | 0 | 0 | 0 | 3 | 18 | |
| BREAST | 974 | 23 | 1200 | 106 | 1291 | 196 | 1193 |
| CCD | 137 | 5 | 261 | 18 | 219 | 25 | 152 |
| ERLYTX | 108 | 1 | 52 | 7 | 85 | 14 | 85 |
| GI | 193 | 3 | 157 | 13 | 158 | 33 | 201 |
| GU | 446 | 5 | 261 | 37 | 450 | 65 | 396 |
| LEUK | 824 | 13 | 678 | 67 | 816 | 130 | 791 |
| LUNG | 530 | 9 | 470 | 46 | 560 | 94 | 572 |
| LYMPH | 386 | 10 | 522 | 30 | 365 | 62 | 377 |
| MELAN | 319 | 1 | 52 | 1 | 12 | 1 | 6 |
| MMYEL | 184 | 2 | 104 | 10 | 122 | 19 | 116 |
| MULT | 15 | 0 | 0 | 7 | 85 | 12 | 73 |
| OTHER | 74 | 3 | 157 | 10 | 122 | 16 | 97 |
| PEOLC | 112 | 3 | 157 | 16 | 195 | 34 | 207 |
| PREV | 248 | 3 | 157 | 21 | 256 | 35 | 213 |
| SURV | 16 | 1 | 52 | 2 | 24 | 6 | 37 |
| SXQOL | 593 | 7 | 365 | 55 | 670 | 92 | 560 |
| Total | 5162 | 89 | 4645 | 446 | 5430 | 837 | 5094 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 2 | 12 | |
| BREAST | 594 | 7 | 365 | 63 | 767 | 120 | 731 |
| ERLYTX | 53 | 1 | 52 | 4 | 49 | 9 | 55 |
| GI | 141 | 1 | 52 | 8 | 97 | 20 | 122 |
| GU | 378 | 3 | 157 | 26 | 317 | 49 | 298 |
| LEUK | 85 | 1 | 52 | 6 | 73 | 11 | 67 |
| LUNG | 151 | 0 | 0 | 6 | 73 | 12 | 73 |
| LYMPH | 242 | 7 | 365 | 16 | 195 | 36 | 219 |
| MELAN | 197 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 115 | 1 | 52 | 4 | 49 | 10 | 61 |
| MULT | 6 | 0 | 0 | 2 | 24 | 4 | 24 |
| OTHER | 38 | 2 | 104 | 3 | 37 | 6 | 37 |
| PREV | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| SXQOL | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2007 | 23 | 1199 | 138 | 1681 | 279 | 1699 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 1 | 6 | |
| CCD | 116 | 4 | 209 | 14 | 170 | 20 | 122 |
| ERLYTX | 11 | 0 | 0 | 1 | 12 | 1 | 6 |
| LEUK | 314 | 7 | 365 | 26 | 317 | 45 | 274 |
| LUNG | 174 | 3 | 157 | 19 | 231 | 44 | 268 |
| LYMPH | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| OTHER | 36 | 1 | 52 | 7 | 85 | 10 | 61 |
| PEOLC | 78 | 2 | 104 | 13 | 158 | 26 | 158 |
| PREV | 243 | 1 | 52 | 19 | 231 | 33 | 201 |
| SURV | 16 | 1 | 52 | 2 | 24 | 6 | 37 |
| SXQOL | 398 | 4 | 209 | 33 | 402 | 60 | 365 |
| Total | 1388 | 23 | 1200 | 134 | 1630 | 246 | 1498 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 3 | 0 | 0 | 0 | 0 | 3 | 18 | |
| BREAST | 785 | 13 | 678 | 85 | 1035 | 160 | 974 |
| CCD | 152 | 4 | 209 | 19 | 231 | 32 | 195 |
| ERLYTX | 64 | 1 | 52 | 5 | 61 | 10 | 61 |
| GI | 149 | 2 | 104 | 9 | 110 | 23 | 140 |
| GU | 395 | 3 | 157 | 26 | 317 | 51 | 310 |
| LEUK | 399 | 8 | 417 | 32 | 390 | 56 | 341 |
| LUNG | 327 | 4 | 209 | 26 | 317 | 57 | 347 |
| LYMPH | 243 | 7 | 365 | 16 | 195 | 36 | 219 |
| MELAN | 197 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 111 | 1 | 52 | 4 | 49 | 10 | 61 |
| MULT | 20 | 0 | 0 | 5 | 61 | 10 | 61 |
| OTHER | 243 | 3 | 157 | 28 | 341 | 43 | 262 |
| PEOLC | 86 | 2 | 104 | 13 | 158 | 26 | 158 |
| PREV | 246 | 1 | 52 | 19 | 231 | 33 | 201 |
| SURV | 16 | 1 | 52 | 2 | 24 | 6 | 37 |
| SXQOL | 400 | 4 | 209 | 33 | 402 | 60 | 365 |
| Total | 3836 | 54 | 2817 | 322 | 3922 | 616 | 3750 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 825 | 19 | 991 | 83 | 1011 | 154 | 937 |
| ERLYTX | 93 | 1 | 52 | 6 | 73 | 11 | 67 |
| GI | 108 | 2 | 104 | 8 | 97 | 22 | 134 |
| GU | 241 | 3 | 157 | 25 | 304 | 42 | 256 |
| LEUK | 107 | 2 | 104 | 10 | 122 | 24 | 146 |
| LUNG | 212 | 2 | 104 | 15 | 183 | 22 | 134 |
| LYMPH | 316 | 10 | 522 | 27 | 329 | 55 | 335 |
| MMYEL | 171 | 2 | 104 | 9 | 110 | 17 | 103 |
| MULT | 15 | 0 | 0 | 7 | 85 | 12 | 73 |
| Total | 2088 | 41 | 2138 | 190 | 2314 | 359 | 2185 |
| Inst. | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| Member | 1978 | 27 | 1409 | 156 | 1899 | 311 | 1893 |
| AFFIL | 124 | 0 | 0 | 12 | 146 | 21 | 128 |
| CCOP/NCORP | 1293 | 19 | 991 | 104 | 1266 | 193 | 1175 |
| Non-SWOG | 1757 | 33 | 1722 | 164 | 1997 | 302 | 1838 |
| Total | 5152 | 79 | 4122 | 436 | 5308 | 827 | 5034 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| GI | S2001 | Rando II, Mets Pancreas , BRCA1/2, Comb Chemo | 1 | N | 23-OCT-25 |
| OTHER | NRGBN012 | Brain, Pre- vs Post-Op Stereotactic Radiosurg | 1 | E | 21-OCT-25 |
| LYMPH | S2207 | LBCL, Transplant Inelig, Targeted Tx + Tafa | 1 | T | 20-OCT-25 |
| ADMIN | STUDYID | STNAME | REGTYPE | Registrations |
|---|---|---|---|---|
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | 13 |
| BREAST | S2212 | Breast, TNBC, Neoadj Chemo + Pembro | 1 | 13 |
| LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 1 | 11 |
| LYMPH | S2308 | FL, LTB, Mosunetuzumab vs Rituximab | 1 | 7 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 2 | 6 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 2 | 5 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 1 | 5 |
| BREAST | A012301 | Breast, Early Stg, Tamoxifen | 1 | 3 |
| BREAST | NRGBR009 | Breast, EarlyStg, Adjuvant Chemo | 1 | 3 |
| SXQOL | S2013 | I-CHECKIT: ICI toxicity risk prediction study | 1 | 3 |
| LYMPH | S2114 | NHL, Rel/Ref, CD19 CAR-T +/- Consolidation | 1 | 3 |
| SXQOL | S2205 | ICE COMPRESS: Reduction of CIPN from Taxanes | 1 | 3 |
| PEOLC | S2408 | Panc Fistula Prevention, Lanreotide | 1 | 3 |